Since the introduction of widespread PSA blood testing, many prostate cancers are now caught at an earlier, localized stage before they have spread. Catching cancer early hugely improves survival ...

Men on active surveillance for low- to intermediate-risk prostate cancer (PCa) have low risk for PCa-related mortality at a median follow-up of 18 years. However, a majority of men do progress and ...

Data from clinical trials have indicated that PSA is prognostic for outcomes, but little is known about real-world trends.

Metastatic prostate cancer can progress in different ways. In some men the disease advances rapidly, while other men have slower-growing cancer and a better prognosis. Researchers are developing ...

Stock image by PDPics from PixabayA Flinders University study shows that bowel cancer survivors face an elevated risk of ...

Results of a study led by VHIO’s Prostate Cancer Group suggest that treatment with CDK4/6 inhibitors followed by senloytic ...

During a live event, Jahan Aghalar, MD, discussed key NCCN-recommended oral therapies and landmark trials for metastatic ...

A Prostate-Cancer Survivor Reacts to Joe Biden’s Diagnosis. By Ed Kilgore, political columnist for Intelligencer since 2015. May 19, 2025. save d. Save this article to read it later.

TAMPA, Fla. (May 16, 2025) — In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University ...

The study, published in JAMA Network Open, analyzed data from more than 5,000 U.S. veterans with metastatic prostate cancer who underwent next-generation sequencing between 2019 and 2023.